Alnylam Pharmaceuticals (ALNY) PT Lowered to $182 at Piper Jaffray; 'Cash of $1.9B to Launch Patisiran & Advance Pipeline'
Tweet Send to a Friend
Piper Jaffray lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $182.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
